[Treatment of the pre-menopause syndrome with a normophasic sequential preparation].
D000328:Adult; D001835:Body Weight / Q000187:drug effects; D002979:Climacteric / Q000187:drug effects; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D008234:Lynestrenol / Q000009:adverse effects / Q000494:pharmacology; D008593:Menopause / Q000187:drug effects*; D008656:Mestranol / Q000009:adverse effects / Q000494:pharmacology; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D013577:Syndrome; D013997:Time Factors
D004338:Drug Combinations; D008656:Mestranol; D008234:Lynestrenol
Die Behandlung des Prämenopausensyndroms mit einem normophasischen Sequenzpräparat.